Suppr超能文献

特定的基因表达特征可描绘肾透明细胞癌的转移潜能。

A specific gene expression signature characterizes metastatic potential in clear cell renal cell carcinoma.

机构信息

Department of Urology, Jena University Hospital, Jena, Germany.

出版信息

J Urol. 2011 Jul;186(1):289-94. doi: 10.1016/j.juro.2011.03.033. Epub 2011 May 20.

Abstract

PURPOSE

The discovery of metastasis markers in clear cell renal cell carcinoma is of critical importance to define individual metastatic risk and select patients for new targeted therapies. We identified potential biomarkers for metastatic clear cell renal cell carcinoma by gene expression analysis.

MATERIALS AND METHODS

We performed transcriptional profiling of 16 primary metastatic and 18 nonmetastatic clear cell renal cell carcinomas with PIQOR™ microarrays. Differentially expressed genes were validated by quantitative real-time polymerase chain reaction.

RESULTS

Genes discriminating between metastatic and nonmetastatic tumors were identified at q <0.001 by significance analysis of microarrays. The metastatic signature contained 127 transcripts. In metastatic samples a greater than 4-fold decrease in expression was detected for the genes CD151 and IKBA (t/F statistic p <0.0001) while the genes MMP16, B7-H1, BCL2L2 and FRA2 showed greater than 4-fold increase of expression in metastatic primary tumors (p <0.0001). Quantitative real-time polymerase chain reaction revealed significant differences in expression among all metastatic tumors, including synchronously and metachronously metastasized tumors, and nonmetastatic tumors for FRA2 (p = 0.032) and CD151 (p = 0.005). In addition, the genes B7-H1 (p = 0.040), FRA2 (p = 0.035), CD151 (p = 0.004) and BCL2L2 (p = 0.035) showed significantly higher expression in early metastasized than in nonmetastatic tumor samples. Different B7-H1 (p = 0.002) and BCL2L2 (p = 0.007) expression levels were found in samples with late metastasis compared to those in synchronously metastasized tumors.

CONCLUSIONS

We determined a metastatic signature of clear cell renal cell carcinoma by microarray analysis. Our data provide the possibility of defining the metastatic potential of primary clear cell renal cell carcinoma based on a select number of genes even in a localized situation.

摘要

目的

在透明细胞肾细胞癌中发现转移标志物对于确定个体转移风险和选择新的靶向治疗患者至关重要。我们通过基因表达分析确定了透明细胞肾细胞癌转移的潜在生物标志物。

材料与方法

我们使用 PIQOR™ 微阵列对 16 例原发转移性和 18 例非转移性透明细胞肾细胞癌进行了转录谱分析。通过实时定量聚合酶链反应验证差异表达基因。

结果

通过微阵列差异表达分析确定了 q <0.001 时区分转移性和非转移性肿瘤的基因。转移特征包含 127 个转录本。在转移性样本中,基因 CD151 和 IKBA 的表达降低了 4 倍以上(t/F 统计 p <0.0001),而基因 MMP16、B7-H1、BCL2L2 和 FRA2 在转移性原发性肿瘤中的表达增加了 4 倍以上(p <0.0001)。实时定量聚合酶链反应显示所有转移性肿瘤之间的表达存在显著差异,包括同时和异时转移的肿瘤和非转移性肿瘤,FRA2(p = 0.032)和 CD151(p = 0.005)。此外,基因 B7-H1(p = 0.040)、FRA2(p = 0.035)、CD151(p = 0.004)和 BCL2L2(p = 0.035)在早期转移的肿瘤样本中的表达明显高于非转移性肿瘤样本。与同时转移的肿瘤相比,晚期转移的肿瘤样本中 B7-H1(p = 0.002)和 BCL2L2(p = 0.007)的表达水平不同。

结论

我们通过微阵列分析确定了透明细胞肾细胞癌的转移特征。我们的数据提供了一种可能性,即使在局部情况下,也可以根据少数基因来确定原发性透明细胞肾细胞癌的转移潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验